Literature DB >> 10342356

Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group.

R Görges1, G Knappe, H Gerl, M Ventz, F Stahl.   

Abstract

We studied plasma cortisol levels at 00:00 h and 08:00 h in 103 patients with Cushing's syndrome and 144 patients in whom this diagnosis had been excluded. These patients were hospitalized in our department from 1975 to 1996. Additionally, we measured these parameters in 20 healthy volunteers and in 5 patients with nonendocrine disease. Corresponding data of urinary free cortisol and low-dose dexamethasone suppression testing were included in the evaluation. Values (mean+/-SD) from patients with Cushing's syndrome: 510+/-232 nmol/l (range 165-1488) for plasma cortisol 00:00 h, 574+/-242 nmol/l (range 236-1612) for plasma cortisol 08:00 h, 991+/-885 nmol/24 h (range 154-4866) for urinary free cortisol and 479+/-304 nmol/l (range 34 - 1,393) for plasma cortisol after 1.5 mg dexamethasone. Values from the patients excluded from Cushing's syndrome: 99+/-76 nmol/l (range 5-371) for plasma cortisol 00:00 h, 393+/-136 nmol/l (range 119-812) for plasma cortisol 08:00 h, 126+/-84 nmol/24 h (range 30-485) for urinary free cortisol, and 64+/-82 nmol/l (range 5-395) for plasma cortisol after 1.5 mg dexamethasone. Values of the healthy volunteers respectively patients with non-endocrine disease: 59+/-30 nmol/l (range 25-130) respectively 127+/-80 nmol/l (range 62-265) for plasma cortisol 00:00 h and 388+/-144 nmol/l (range 157-651) respectively 498+/-113 nmol/l (range 302-581) for plasma cortisol 08:00 h. None of the Cushing patients exhibited a 00:00 h plasma cortisol below 140 nmol/l and only one had a urinary free cortisol below 200 nmol/24 h, whereas 4 were complete dexamethasone suppressors. The diagnostic value of these parameters was examined based on various cutoffs. We recommend determination of midnight plasma cortisol as an efficient and simple additional procedure for the diagnosis of Cushing's syndrome. The sensitivity and specificity of this procedure is similar to urinary free cortisol and slightly above the low-dose dexamethasone suppression testing in our hospitalized patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10342356     DOI: 10.1007/BF03343551

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  33 in total

1.  Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome.

Authors:  T Mengden; P Hubmann; J Müller; P Greminger; W Vetter
Journal:  Clin Investig       Date:  1992-07

2.  Variable hormonogenesis in Cushing's syndrome.

Authors:  M S Shapiro; L Shenkman
Journal:  Q J Med       Date:  1991-04

3.  Overnight dexamethasone suppression test: normal responses and the diagnosis of Cushing's syndrome.

Authors:  S L Blethen; F I Chasalow
Journal:  Steroids       Date:  1989-08       Impact factor: 2.668

4.  Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone.

Authors:  R D Brown; G R Van Loon; D N Orth; G W Liddle
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

5.  Cortisol is secreted episodically in Cushing's syndrome.

Authors:  L Hellman; E D Weitzman; H Roffwarg; D K Fukushima; K Yoshida
Journal:  J Clin Endocrinol Metab       Date:  1970-05       Impact factor: 5.958

6.  Evaluation of a competitive binding assay for cortisol using horse transcortin.

Authors:  F Stahl; W Hubl; D Schnorr; G Dörner
Journal:  Endokrinologie       Date:  1978-05

7.  Urinary free corticoids: an evaluation of their usefulness in the diagnosis of Cushing's syndrome.

Authors:  G Vidal Trecan; M H Laudat; P Thomopoulos; J P Luton; H Bricaire
Journal:  Acta Endocrinol (Copenh)       Date:  1983-05

Review 8.  The Cushing syndrome: an update on diagnostic tests.

Authors:  T B Kaye; L Crapo
Journal:  Ann Intern Med       Date:  1990-03-15       Impact factor: 25.391

9.  A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.

Authors:  J Newell-Price; P Trainer; L Perry; J Wass; A Grossman; M Besser
Journal:  Clin Endocrinol (Oxf)       Date:  1995-11       Impact factor: 3.478

10.  Short-term fluctuations in plasma cortisol in Cushing's syndrome.

Authors:  H Vetter; R Strass; J M Bayer; R Beckerhoff; H Armbruster; W Vetter
Journal:  Clin Endocrinol (Oxf)       Date:  1977-01       Impact factor: 3.478

View more
  12 in total

1.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

2.  Diurnal Plasma Cortisol Measurements Utility in Differentiating Various Etiologies of Endogenous Cushing Syndrome.

Authors:  A Tirosh; M B Lodish; G Z Papadakis; C Lyssikatos; E Belyavskaya; C A Stratakis
Journal:  Horm Metab Res       Date:  2016-09-19       Impact factor: 2.936

Review 3.  The diagnosis of Cushing's syndrome.

Authors:  Ty B Carroll; James W Findling
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

Review 4.  Cushing's disease.

Authors:  Martina De Martin; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

5.  Diagnostic efficacy of midnight cortisol and midnight ACTH in the diagnosis and localisation of Cushing's syndrome.

Authors:  Mathew John; Anurag R Lila; Tushar Bandgar; Padma S Menon; Nalini S Shah
Journal:  Pituitary       Date:  2010       Impact factor: 4.107

Review 6.  Evaluation of the hypothalamic-pituitary-adrenal axis function in childhood and adolescence.

Authors:  George P Chrousos; Tomoshige Kino; Evangelia Charmandari
Journal:  Neuroimmunomodulation       Date:  2009-06-29       Impact factor: 2.492

7.  [Adrenal incidentalomas].

Authors:  P Langer; J Waldmann; M Rothmund
Journal:  Chirurg       Date:  2007-08       Impact factor: 0.955

8.  Glucocorticoid response elements and 11 beta-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression.

Authors:  Yong Liu; Domagoj Mladinov; Jennifer L Pietrusz; Kristie Usa; Mingyu Liang
Journal:  Cardiovasc Res       Date:  2008-08-20       Impact factor: 10.787

9.  Severe obesity confounds the interpretation of low-dose dexamethasone test combined with the administration of ovine corticotrophin-releasing hormone in childhood Cushing syndrome.

Authors:  Dalia L Batista; Nikos Courcoutsakis; Jehan Riar; Margaret F Keil; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2008-08-26       Impact factor: 5.958

10.  Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.

Authors:  P Putignano; M Bertolini; M Losa; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2003-06       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.